KLEIN MATTHEW B. (Chief Development Officer) sold 3.1% of their position (12.57K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $917.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 5/15/2026ACC: 0001808968-26-000015
Officer· Chief Development Officer
Since Apr 2020
-72.00
Net shares
Net seller
$917.2K
Total sold
4
Open market trades
0B · 4S
5
Total transactions
12.50K acquired · 12.57K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
3.2%
5/13/2026
394.07K→406.57K
Common Stock
Direct
Shares
−679.00
Price / share
$73.06
Trade value
$49.61K
% of position
0.2%
5/14/2026
406.57K→405.89K
Common Stock
Direct
Shares
−7.22K
Price / share
$73.08
Trade value
$527.71K
% of position
1.8%
5/14/2026
405.89K→398.67K
Common Stock
Direct
Shares
−2.10K
Price / share
$73.08
Trade value
$153.47K
% of position
0.5%
5/14/2026
398.67K→396.57K
Common Stock
Direct
Shares
−2.57K
Price / share
$72.46
Trade value
$186.37K
% of position
0.6%
5/14/2026
396.57K→394K
Total
Net shares
−72.00
Net value
-$917.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2026 | A · Award | +12.50K | — | — | 3.2% | 394.07K | 406.57K |
| Common Stock Direct | 5/14/2026 | S · Sale | −679.00 | $73.06 | $49.61K | 0.2% | 406.57K | 405.89K |
| Common Stock Direct | 5/14/2026 | S · Sale | −7.22K | $73.08 | $527.71K | 1.8% | 405.89K | 398.67K |
| Common Stock Direct | 5/14/2026 | S · Sale | −2.10K | $73.08 | $153.47K | 0.5% | 398.67K | 396.57K |
| Common Stock Direct | 5/14/2026 | S · Sale | −2.57K | $72.46 | $186.37K | 0.6% | 396.57K | 394K |
| Total | −72.00 | -$917.15K | ||||||
Derivative Transactions0
No derivative transactions reported